NOS3 and dementia: Of the targets, PTGS1 and PTGS2 (each with degree, 5) had the highest degree of connectivity with the compounds, followed by NOS3, INSR, NR1I3, NR1I2, HMOX1, ACHE, PPARG, MAOA, and MAOB (each with degree ≥3) suggesting the implication of these gene products as a prospective drug-target for CP compounds in the dementia management.